Published • loading... • Updated
Breakthrough: China’s First Approved Solid Tumor CAR-T Therapy Paves the Way for Industry Transformation
Summary by chinamoneynetwork.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Breakthrough: China’s First Approved Solid Tumor CAR-T Therapy Paves the Way for Industry Transformation
The National Medical Products Administration has approved the listing of KaiXing Life Technology (Shanghai) Co., Ltd.'s CAR-T therapy, named Kailimei, for the treatment of advanced gastric/esophagogastric junction adenocarcinoma. This marks the global debut of a CAR-T therapy for solid tumor treatment, a significant milestone in the field of cell and gene therapy (CGT). The breakthrough by KaiXing Life Technology signifies China's leap from "kee…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
